Pfizer in advanced talks to buy firm making sickle cell drugs

Pfizer Inc is in advanced talks to buy sickle cell drugmaker Global Blood Therapeutics for about $5 billion, the Wall Street Journal reports

Related Keywords

United States , ,Pfizer ,Biohaven Pharmaceutical Holding ,Pfizer Inc ,Arena Pharmaceuticals ,Amgen Inc ,Chemocentryx Inc ,Global Blood Therapeutics ,Wall Street Journal ,Global Blood ,York Based Pfizer ,Trillium Therapeutics ,